Replies to post #69877 on Biotech Values

[DewDiligence]

>CAMH – Rob Khederian was the idiot…<

A reasonable selection, IMO. The counter-argument is that Khederian was in the same boat with Diane Goostree of ARTE (#msg-34091488) in trying to sell a product for which there was simply no demand.

>…who signed the deal with St. Jude Medical that allowed CAMH to wither<

I know it’s bad form to say, “I told you so,” but I told you so:

#msg-18092546 (3/21/07)

››
This deal looks bearish… CAMH is raising
sales guidance for 2007 by a scant $2M on
account of this deal, which is astonishingly
low unless STJ has no real intention of
pushing the product. There is no up-front
payment other than the $12.5M in equity…
‹‹